While the role of KIR2DL4 in the NK cells in the tumor microenvironment remains uncharacterized, we found that, in the absence of HLA-G, KIR2DL4 forms a feedback circuit with IFN-γ to promote trastuzumab-induced ADCC in vitro. Here, HLA-G is linked to neoplasm.